ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,265Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 387

$833K Total Retail Price of All Prescriptions

Rank: 47 out of 387

408 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 8,004 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 505 385 1 2
HYDROCODONE-ACETAMINOPHEN 466 271 S3 2 1
OMEPRAZOLE 461 297 3 4
AMLODIPINE BESYLATE 280 256 4 6
TRAMADOL HCL 274 190 5 14
LISINOPRIL 242 198 6 3
ZOLPIDEM TARTRATE 242 170 6 16
SIMVASTATIN 235 168 8 5
FUROSEMIDE 234 154 9 7
POTASSIUM CHLORIDE 230 160 10 9
PRAVASTATIN SODIUM 208 181 11 15
GABAPENTIN 183 144 12 10
METFORMIN HCL 173 129 13 8
HYDROCHLOROTHIAZIDE 161 121 14 12
CARVEDILOL 159 133 15 21
FLUTICASONE PROPIONATE 155 100 16 29
TRAZODONE HCL 154 84 17 37
METOPROLOL SUCCINATE 125 92 18 18
MELOXICAM 115 87 19 22
TAMSULOSIN HCL 111 83 20 32
CLOPIDOGREL 110 95 21 25
LYRICA 110 90 21 66
PANTOPRAZOLE SODIUM 103 87 23 48
CRESTOR 98 80 24 34
WARFARIN SODIUM 92 79 25 17
CYCLOBENZAPRINE HCL 91 35 R 26 42
PROMETHAZINE HCL 91 33 R 26 82
ATORVASTATIN CALCIUM 87 76 28 13
CITALOPRAM HBR 87 70 28 19
ROPINIROLE HCL 83 62 30 91
DONEPEZIL HCL 83 83 30 27
CLONIDINE HCL 82 64 32 38
LOSARTAN POTASSIUM 80 62 33 24
NEXIUM 80 27 33 26
FINASTERIDE 78 63 35 95
FENTANYL 73 48 S2 36 80
MORPHINE SULFATE ER 72 25 S2 37 79
CIPROFLOXACIN HCL 72 54 37 56
DIOVAN 71 45 39 33
CELEBREX 70 34 40 72
RAMIPRIL 68 59 41 119
DIVALPROEX SODIUM 68 33 41 113
AMITRIPTYLINE HCL 68 24 R 41 62
SINGULAIR 66 35 44 83
NAMENDA 62 62 45 35
CYMBALTA 61 32 46 44
PLAVIX 61 55 46 39
LANTUS SOLOSTAR 59 46 48 102
ESTRADIOL 59 31 R 48 105
AZITHROMYCIN 58 36 50 49
RISPERIDONE 58 29 50 70
FLUCONAZOLE 57 32 52 160
TOPIRAMATE 57 15 52 140
DOXAZOSIN MESYLATE 56 50 54 75
SPIRONOLACTONE 55 33 55 67
VERAPAMIL ER 55 43 55 87
LEVOXYL 54 37 57 216
HYDROXYZINE HCL 52 43 R 58 210
ALLOPURINOL 52 34 58 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 44 60 90
NITROSTAT 50 26 61 208
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.